Emails Offer Look Into Whistleblower Charges of Cronyism Behind Potential COVID-19 Drug
A demoted pandemic official expressed concern about the safety of an unproven coronavirus drug, according to a whistleblower complaint.
A scorching whistleblower complaint filed by immunologist Rick Bright ended in him being removed in April as head of the Biomedical Advanced Research and Development Authority. So what did it say? For
& Charles Piller report.